BioMed Central | Articles which cite: Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder. Deberdt W, Lipkovich I, Heinloth AN, Liu L, Kollack-Walker S, Edwards SE, Hoffmann VP, Hardy TA Ther Clin Risk Manag 2008 Aug, 4:713-20 [PubMed Central] [PubMed] [Related articles]
2.	Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia. Faries DE, Ascher-Svanum H, Nyhuis AW, Kinon BJ BMC Psychiatry 2009, 9:54 [PubMed Central] [PubMed] [Related articles]
3.	Predicting the brain response to treatment using a Bayesian hierarchical model with application to a study of schizophrenia. Guo Y, DuBois Bowman F, Kilts C Hum Brain Mapp 2008 Sep, 29:1092-109 [PubMed Central] [PubMed] [Related articles]
4.	Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER. Birnbaum M, Sharif Z Patient Prefer Adherence 2008, 2:233-40 [PubMed Central] [PubMed] [Related articles]
5.	Predictors of premature discontinuation of treatment in multiple disease states. Nantz E, Liu-Seifert H, Skljarevski V Patient Prefer Adherence 2009, 3:31-43 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 4 articles in BioMed Central

printer friendly

to [Help]